Pall Corp. To Open Latest Life Sciences Center of Excellence in New England
September 19, 2012
PORT WASHINGTON, N.Y., - Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today announced it will be opening a state-of-the-art Life Sciences Center of Excellence in Westborough, Massachusetts. Strategically located in the heart of Massachusetts’ renowned life-science cluster, the new center will provide Pall life sciences customers in the northeast region of [...]
September 19, 2012
CARLSBAD, Calif. and BEIJING, -- Life Technologies Corporation — (NASDAQ: LIFE), a world-leading biotechnology company, today announced the completion of a state-of-the-art facility in Beijing where the most advanced DNA testing solutions will be manufactured and readily available to help forensics labs and law enforcement agencies solve crimes more cost effectively in China. DNA testing [...]
September 19, 2012
Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA* of Darmstadt, Germany, today announced a donation of $5,000 to Everybody Wins! Metro Boston- the local chapter of a national literacy and mentoring non-profit organization. Their signature program, Power Lunch, provides the opportunity for EMD Millipore employees and other local professionals to read [...]
Sigma-Aldrich Elects Michael Marberry As Director
September 19, 2012
ST. LOUIS, -- The Board of Directors of Sigma-Aldrich Corporation (NASDAQ: SIAL) has elected Michael Marberry as a Director of the Company. Mr. Marberry (age 54) is President and CEO of J.M. Huber Corporation, a diversified, multinational supplier of engineered materials, natural resources and technology-based services to customers spanning many industries from paper and energy [...]
September 19, 2012
Cambridge, MA -- GnuBIO www.gnubio.com announced today that it has been awarded a $4.5 million Phase II SBIR grant over the next three years through the National Human Genome Research Institute’s (NHGRI) Advanced DNA Sequencing Technology Program. After a rigorous process, the grant committee at the NIH chose six projects to fund for this competitive [...]
September 19, 2012
Salt Lake City, UT, – e-SENS Corporation, based in Research Park in Salt Lake City, UT, today announced initial investments have been secured, and a new office and lab are now open and operating, as the company prepares its first product for the market, expecting to ship samples within a year. That product will be [...]
Pathogenica and Life Technologies EMEA Partner to Control Hospital Acquired Infections
September 19, 2012
Life Technologies (NASDAQ: LIFE) announced an exclusive agreement with Pathogenica, Boston, Massachusetts, to co-market and distribute for research use, the Pathogenica HAI (Hospital Acquired Infection) BioDetection Kit on the Ion Torrent PGM[ TM ] in Europe, the Middle East and Africa (EMEA). Based on Pathogenica's DxSeq[ TM ] technologyand the Ion Torrent[ TM ] sequencing [...]
September 19, 2012
SAN DIEGO, CA, and BERLIN, GERMANY –— Genalyte, Inc., a life sciences company developing and commercializing innovative next generation multiplexing technology, and Scienion AG, a life science company developing microarray and ultra-low volume liquid handling systems, today announced an agreement under which Genalyte will market Scienion’s sciFLEXARRAYERTM automated liquid dispensers along with Genalyte’s multiplexed MaverickTM [...]
New SPECTROMAXx: A Top Seller For Metal Analysis Is Now Even Easier To Operate
September 19, 2012
Kleve, —SPECTRO has brought onto the market the third generation of its highly successful SPECTROMAXx stationary metal analyzer. The latest generation takes over where the second generation SPECTROMAXx, developed in 2009, leaves off. SPECTRO has improved operation of the instrument with the use of toolbar buttons, a user management system, and a separation of operation [...]
September 19, 2012
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Cambridge, U.K.-based BlueGnome Ltd. for an undisclosed sum. BlueGnome, now a wholly owned subsidiary of Illumina, is a leading provider of solutions for the screening of genetic abnormalities associated with developmental delay, cancer, and infertility. "The BlueGnome acquisition supports Illumina's goal to be [...]

